Core V2 lets capital committed to Symbiotic vaults be routed into Aave and Morpho when idle, with automatic recall when enforcement is needed. Each vault keeps independent risk parameters—allocation limits, accepted collateral types, and loss conditions—executed onchain, and pooling reportedly delivers 70% more capital efficiency than standalone pools. The first V2 product, Liquid Lane, enables near-instant RWA redemptions for stablecoins; Midas was first issuer, with Fasanara Capital and KPK as curators. Nexus Mutual will use it for reinsurance capacity, and Cap for institutional credit guarantees. Symbiotic previously raised $29 million in a Series A led by Pantera.

AI summary of the linked source — not editorial content.

Explore the topic

Loading related coverage…

Comments

Loading comments…